Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 3:44 PM
Ignite Modification Date:
2025-12-25 @ 1:52 PM
NCT ID:
NCT01953692
Group ID:
EG007
Title:
Cohort 5: R/R DLBCL Pembrolizumab+Lenalidomide 20 mg (RP2D)
Description:
Participants received pembrolizumab 200 mg by IV infusion on Day 1 of each 21-day cycle + lenalidomide 20 mg orally (PO) every day (QD) for 21 consecutive days with 7 days off within 28-day cycles. The 20 mg dose of lenalidomide is the RP2D.
Deaths Number Affected:
8
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
13
Other Number Affected:
13
Other Number At Risk:
13
Study:
NCT01953692
Results Section:
NCT01953692
Adverse Events Module:
NCT01953692